Cytokines and human fibrosis, Eur Cytokine Netw, vol.1, pp.215-219, 1990. ,
TGF-??-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing, Journal of Dermatological Science, vol.35, issue.2, pp.83-92, 2004. ,
DOI : 10.1016/j.jdermsci.2003.12.006
URL : https://hal.archives-ouvertes.fr/inserm-00147401
Connective tissue growth factor: a mediator of TGF-?? action on fibroblasts, Cytokine & Growth Factor Reviews, vol.8, issue.3, pp.171-179, 1997. ,
DOI : 10.1016/S1359-6101(97)00010-5
Insights Into the Molecular Mechanism of Chronic Fibrosis: The Role of Connective Tissue Growth Factor in Scleroderma, Journal of Investigative Dermatology, vol.122, issue.1, pp.1-6, 2004. ,
DOI : 10.1046/j.0022-202X.2003.22133.x
SPECIFICITY AND VERSATILITY IN TGF-?? SIGNALING THROUGH SMADS, Annual Review of Cell and Developmental Biology, vol.21, issue.1, pp.659-693, 2005. ,
DOI : 10.1146/annurev.cellbio.21.022404.142018
Molecular and Cell Biology of TGF-??, Mineral and Electrolyte Metabolism, vol.24, issue.2-3, pp.111-119, 1998. ,
DOI : 10.1159/000057358
Making sense of latent TGFbeta activation, Journal of Cell Science, vol.116, issue.2, pp.217-224, 2003. ,
DOI : 10.1242/jcs.00229
New insights into TGF-?????Smad signalling, Trends in Biochemical Sciences, vol.29, issue.5, pp.265-273, 2004. ,
DOI : 10.1016/j.tibs.2004.03.008
Oligomeric Structure of Type I and Type II Transforming Growth Factor ?? Receptors: Homodimers Form in the ER and Persist at the Plasma Membrane, The Journal of Cell Biology, vol.15, issue.4, pp.767-777, 1998. ,
DOI : 10.1038/383168a0
SARA, a FYVE Domain Protein that Recruits Smad2 to the TGF?? Receptor, Cell, vol.95, issue.6, pp.779-791, 1998. ,
DOI : 10.1016/S0092-8674(00)81701-8
A structural basis for mutational inactivation of the tumour suppressor Smad4, Nature, vol.388, pp.87-93, 1997. ,
Mechanisms of TGF-?? Signaling from Cell Membrane to the Nucleus, Cell, vol.113, issue.6, pp.685-700, 2003. ,
DOI : 10.1016/S0092-8674(03)00432-X
Regulation of Collagen Gene Expression, Prog Nucleic Acid Res Mol Biol, vol.37, pp.67-106, 1989. ,
DOI : 10.1016/S0079-6603(08)60695-9
Factors involved in the regulation of type I collagen gene expression: implication in fibrosis, Exp Biol Med (Maywood), vol.227, pp.301-314, 2002. ,
Pathogenesis of fibrosis: type 1 collagen and the skin, Journal of Molecular Medicine, vol.76, issue.3-4, pp.266-274, 1998. ,
DOI : 10.1007/s001090050216
Functional analysis of human alpha 1(I) procollagen gene promoter. Differential activity in collagen-producing and -nonproducing cells and response to transforming growth factor beta 1, J Biol Chem, vol.269, pp.12684-12691, 1994. ,
Transforming growth factorbeta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site, J Biol Chem, vol.269, pp.14828-14834, 1994. ,
Overlapping pathways mediate the opposing actions of tumor necrosis factor-alpha and transforming growth factor-beta on alpha 2(I) collagen gene transcription, J Biol Chem, vol.270, pp.3353-3358, 1995. ,
An AP-1 Binding Sequence Is Essential for Regulation of the Human 2(I) Collagen (COL1A2) Promoter Activity by Transforming Growth Factor-, Journal of Biological Chemistry, vol.271, issue.6, pp.3272-3278, 1996. ,
DOI : 10.1074/jbc.271.6.3272
Blocking Sp1 Transcription Factor Broadly Inhibits Extracellular Matrix Gene Expression In Vitro and In Vivo: Implications for the Treatment of Tissue Fibrosis, Journal of Investigative Dermatology, vol.116, issue.5, pp.755-763, 2001. ,
DOI : 10.1046/j.1523-1747.2001.01326.x
Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-??: Involvement of Smad 3, Journal of Investigative Dermatology, vol.112, issue.1, pp.49-57, 1999. ,
DOI : 10.1046/j.1523-1747.1999.00477.x
Sp1 and Smad Proteins Cooperate to Mediate Transforming Growth Factor-??1-induced ??2(I) Collagen Expression in Human Glomerular Mesangial Cells, Journal of Biological Chemistry, vol.276, issue.10, pp.6983-6992, 2001. ,
DOI : 10.1074/jbc.M006442200
The steroid receptor co-activator-1 (SRC-1) potentiates TGF-??/Smad signaling: role of p300/CBP, Oncogene, vol.24, issue.11, pp.1936-1945, 2005. ,
DOI : 10.1038/sj.onc.1208343
SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor ??, Proceedings of the National Academy of Sciences, vol.95, issue.25, pp.14769-14774, 1998. ,
DOI : 10.1073/pnas.95.25.14769
Direct binding of Smad3 and Smad4 to critical TGFbeta -inducible elements in the promoter of human plasminogen activator inhibitor-type 1gene, The EMBO Journal, vol.17, issue.11, pp.3091-3100, 1998. ,
DOI : 10.1093/emboj/17.11.3091
Interaction of Smad3 with a proximal smad-binding element of the human ?2(I) procollagen gene promoter required for transcriptional activation by TGF-?, Journal of Cellular Physiology, vol.2, issue.3, pp.381-392, 2000. ,
DOI : 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O
Identification of Novel TGF-??/Smad Gene Targets in Dermal Fibroblasts using a Combined cDNA Microarray/Promoter Transactivation Approach, Journal of Biological Chemistry, vol.276, issue.20, pp.17058-17062, 2001. ,
DOI : 10.1074/jbc.M100754200
Transforming Growth Factor-?? Repression of Matrix Metalloproteinase-1 in Dermal Fibroblasts Involves Smad3, Journal of Biological Chemistry, vol.276, issue.42, pp.38502-38510, 2001. ,
DOI : 10.1074/jbc.M107081200
Differential Expression of Transforming Growth Factor-?? Receptors I and II and Activation of Smad 3 in Keloid Fibroblasts, Plastic and Reconstructive Surgery, vol.108, issue.2, pp.423-429, 2001. ,
DOI : 10.1097/00006534-200108000-00022
Smad3 signalling plays an important role in keloid pathogenesis via epithelial???mesenchymal interactions, The Journal of Pathology, vol.65, issue.2, pp.232-242, 2005. ,
DOI : 10.1002/path.1826
TGF-??1 and radiation fibrosis: a master switch and a specific therapeutic target?, International Journal of Radiation Oncology*Biology*Physics, vol.47, issue.2, pp.277-290, 2000. ,
DOI : 10.1016/S0360-3016(00)00435-1
Pathophysiology of irradiated skin and breast, International Journal of Radiation Oncology*Biology*Physics, vol.31, issue.5, pp.1171-1185, 1995. ,
DOI : 10.1016/0360-3016(94)00423-I
Chronic cutaneous damage after accidental exposure to ionizing radiation: The Chernobyl experience, Journal of the American Academy of Dermatology, vol.30, issue.5, pp.719-723, 1994. ,
DOI : 10.1016/S0190-9622(08)81501-0
A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis, International Journal of Radiation Oncology*Biology*Physics, vol.33, issue.1, pp.99-109, 1995. ,
DOI : 10.1016/0360-3016(95)00095-G
Transforming growth factor-?? signaling through the Smad proteins: Role in systemic sclerosis, Autoimmunity Reviews, vol.5, issue.8, pp.563-569, 2006. ,
DOI : 10.1016/j.autrev.2006.06.001
URL : https://hal.archives-ouvertes.fr/inserm-00166114
Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts, Arthritis & Rheumatism, vol.42, issue.7, pp.1964-1978, 2003. ,
DOI : 10.1002/art.11157
Deficient Smad7 expression: A putative molecular defect in scleroderma, Proceedings of the National Academy of Sciences, vol.99, issue.6, pp.3908-3913, 2002. ,
DOI : 10.1073/pnas.062010399
The Role of Transforming Growth Factor ?? in Lung Development and Disease, Chest, vol.125, issue.2, pp.754-765, 2004. ,
DOI : 10.1378/chest.125.2.754
Analysis of local mRNA expression for extracellular matrix proteins and growth factors using in situ hybridization in fibroproliferative lung disorders Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis, Chest Proc Natl Acad Sci, vol.99, issue.88, pp.55-56, 1991. ,
Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma, J Rheumatol, vol.22, pp.1876-1883, 1995. ,
Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation, European Respiratory Journal, vol.14, issue.5, pp.1136-1144, 1999. ,
DOI : 10.1183/09031936.99.14511369
The complex pattern of SMAD signaling in the cardiovascular system???, Cardiovascular Research, vol.69, issue.1, pp.15-25, 2006. ,
DOI : 10.1016/j.cardiores.2005.07.007
-induced collagen I expression in human mesangial cells, American Journal of Physiology - Renal Physiology, vol.285, issue.3, pp.413-422, 2003. ,
DOI : 10.1152/ajprenal.00082.2003
TGF-?? Signaling in Renal Disease, Journal of the American Society of Nephrology, vol.13, issue.10, pp.2600-2610, 2002. ,
DOI : 10.1097/01.ASN.0000033611.79556.AE
Roles of TGF-beta in hepatic fibrosis, Frontiers in Bioscience, vol.7, issue.4, pp.793-807, 2002. ,
DOI : 10.2741/A812
Smad3 as a mediator of the fibrotic response, International Journal of Experimental Pathology, vol.282, issue.2, pp.47-64, 2004. ,
DOI : 10.1111/j.0959-9673.2004.00377.x
Mice Lacking Smad3 Are Protected Against Cutaneous Injury Induced by Ionizing Radiation, The American Journal of Pathology, vol.160, issue.3, pp.1057-1068, 2002. ,
DOI : 10.1016/S0002-9440(10)64926-7
Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice, American Journal of Physiology - Lung Cellular and Molecular Physiology, vol.282, issue.3, pp.585-593, 2002. ,
DOI : 10.1152/ajplung.00151.2001
Smad3 Null Mice Develop Airspace Enlargement and Are Resistant to TGF-??-Mediated Pulmonary Fibrosis, The Journal of Immunology, vol.173, issue.3, pp.2099-2108, 2004. ,
DOI : 10.4049/jimmunol.173.3.2099
Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice, Journal of Clinical Investigation, vol.104, issue.1, pp.5-11, 1999. ,
DOI : 10.1172/JCI6094
Smad3 is key to TGF-??-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis, Cytokine & Growth Factor Reviews, vol.17, issue.1-2, pp.19-27, 2006. ,
DOI : 10.1016/j.cytogfr.2005.09.008
Transforming growth factor-?? and connective tissue growth factor: key cytokines in scleroderma pathogenesis, Current Opinion in Rheumatology, vol.13, issue.6, pp.505-511, 2001. ,
DOI : 10.1097/00002281-200111000-00010
CTGF and SMADs, Maintenance of Scleroderma Phenotype Is Independent of SMAD Signaling, Journal of Biological Chemistry, vol.276, issue.14, pp.10594-10601, 2001. ,
DOI : 10.1074/jbc.M010149200
Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression, International Journal of Radiation Oncology*Biology*Physics, vol.56, issue.2, pp.561-572, 2003. ,
DOI : 10.1016/S0360-3016(02)04601-1
Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats, The Journal of Gene Medicine, vol.22, issue.7, pp.889-900, 2006. ,
DOI : 10.1002/jgm.894
Connective Tissue Growth Factor Is Crucial to Inducing a Profibrotic Environment in ???Fibrosis-Resistant??? Balb/c Mouse Lungs, American Journal of Respiratory Cell and Molecular Biology, vol.31, issue.5, pp.510-516, 2004. ,
DOI : 10.1165/rcmb.2004-0158OC
Halofuginone: A Novel Antifibrotic Therapy, General Pharmacology: The Vascular System, vol.30, issue.4, pp.445-450, 1998. ,
DOI : 10.1016/S0306-3623(97)00307-8
Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma, Biology of Blood and Marrow Transplantation, vol.9, issue.7, pp.417-425, 2003. ,
DOI : 10.1016/S1083-8791(03)00151-4
Targeted therapy comes of age in scleroderma, Trends in Immunology, vol.26, issue.11, pp.596-602, 2005. ,
DOI : 10.1016/j.it.2005.09.002
Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-?? signaling, Cell and Tissue Research, vol.5, issue.1, pp.153-166, 2007. ,
DOI : 10.1007/s00441-006-0330-1
Tumor Necrosis Factor-?? Inhibits Transforming Growth Factor-?? /Smad Signaling in Human Dermal Fibroblasts via AP-1 Activation, Journal of Biological Chemistry, vol.275, issue.39, pp.30226-30231, 2000. ,
DOI : 10.1074/jbc.M005310200
URL : https://hal.archives-ouvertes.fr/inserm-00150046
Induction of the AP-1 members c-Jun and JunB by TGF-??/Smad suppresses early Smad-driven gene activation, Oncogene, vol.20, issue.18, pp.2205-2211, 2001. ,
DOI : 10.1038/sj.onc.1204347
A Central Role for the JNK Pathway in Mediating the Antagonistic Activity of Pro-inflammatory Cytokines against Transforming Growth Factor-??-driven SMAD3/4-specific Gene Expression, Journal of Biological Chemistry, vol.278, issue.3, pp.1585-1593, 2003. ,
DOI : 10.1074/jbc.M206927200
Smad3/AP-1 interactions control transcriptional responses to TGF-?? in a promoter-specific manner, Oncogene, vol.20, issue.26, pp.3332-3340, 2001. ,
DOI : 10.1038/sj.onc.1204448
Distinct involvement of the Jun-N-terminal kinase and NF-??B pathways in the repression of the human COL1A2 gene by TNF-??, EMBO reports, vol.3, issue.11, pp.1069-1074, 2002. ,
DOI : 10.1093/embo-reports/kvf219
Cyclic adenosine 3???,5???-monophosphate-elevating agents inhibit transforming growth factor-??-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism, Oncogene, vol.22, issue.55, pp.8881-8890, 2003. ,
DOI : 10.1038/sj.onc.1206871
URL : https://hal.archives-ouvertes.fr/inserm-00147460
Induction of CTGF by TGF-??1 in normal and radiation enteritis human smooth muscle cells: Smad/Rho balance and therapeutic perspectives, Radiotherapy and Oncology, vol.76, issue.2, pp.219-225, 2005. ,
DOI : 10.1016/j.radonc.2005.06.029